Back to search

Varenicline as compared to bupropion in smoking-cessation therapy—Cost–utility results for Sweden 2003

Data up to Jan 2025

Published2008
Citations44
References31

Total Citations Per Year

Abstract

References (31)

Mathematical Models in Biology

2005 • 2,010 citations

Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

2006 • 1,630 citations

Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

2006 • 1,343 citations

Antidepressants for smoking cessation

2020 • 1,245 citations

The Mortality of Doctors in Relation to Their Smoking Habits

1954 • 915 citations

Economic Evaluation in Health Care: Merging Theory with Practice

2002 • 735 citations

Antidepressants for smoking cessation

2003 • 703 citations

Effect of Maintenance Therapy With Varenicline on Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

2006 • 664 citations

Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study

2003 • 603 citations

Accounting for future costs in medical cost-effectiveness analysis

1997 • 447 citations

Defining post-stroke recovery: implications for design and interpretation of drug trials

2000 • 393 citations

Health Economic Guidelines—Similarities, Differences and Some Implications

2001 • 330 citations

Smoking vs Other Risk Factors as the Cause of Smoking-Attributable Deaths

2000 • 315 citations

A Meta-Analysis of Quality-of-Life Estimates for Stroke

2003 • 211 citations

Cost-effectiveness of the Transdermal Nicotine Patch as an Adjunct to Physicians' Smoking Cessation Counseling

1996 • 196 citations

Fish consumption and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population.

2013 • 154 citations

Smoking relapse after 2 years of abstinence: findings from the VA Normative Aging Study

2002 • 148 citations

Development of an Economic Model to Assess the Cost Effectiveness of Treatment Interventions for Chronic Obstructive Pulmonary Disease

2005 • 137 citations

Cost of stroke in Sweden: An incidence estimate

2004 • 128 citations

Quality of Life and Utility in Patients with Non-Small Cell Lung Cancer

2001 • 117 citations

Early rheumatoid arthritis: strategies for prevention and management

2007 • 117 citations

Tobacco Smoking and Gastric Cancer Risk: An Evaluation Based on a Systematic Review of Epidemiologic Evidence among the Japanese Population

2006 • 99 citations

Late relapse/sustained abstinence among former smokers: a longitudinal study

2004 • 92 citations

The economic impact of smoking in Germany

2000 • 88 citations

Development of the health and economic consequences of smoking interactive model

2001 • 75 citations

Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands

2007 • 72 citations

The Cost Utility of Bupropion in Smoking Cessation Health Programs

2006 • 39 citations

Cost Effectiveness of Treating Low HDL-Cholesterol in the Primary Prevention of Coronary Heart Disease

2005 • 37 citations

Studies in health economics : modelling and data analysis of costs and survival

2002 • 35 citations

Smoking, healthcare cost, and loss of productivity in Sweden 2001

2006 • 31 citations

More on survival consumption costs in cost‐utility analysis

2006 • 26 citations

Cited By (0)

Loading...